Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Characterization and Investigation of Stigmasterol Isolated from Rodent Tuber Mutant Plant (Typhonium flagelliforme), Its Molecular Docking as Anticancer on MF-7 Cells

Version 1 : Received: 12 July 2021 / Approved: 13 July 2021 / Online: 13 July 2021 (08:27:04 CEST)

How to cite: Sianipar, N.F.; Hadisaputri, Y.E.; Assidqi, K.; Salam, S.; Yusuf, M.; Destiarani, W.; Purnamaningsih, R.; So, I.G. Characterization and Investigation of Stigmasterol Isolated from Rodent Tuber Mutant Plant (Typhonium flagelliforme), Its Molecular Docking as Anticancer on MF-7 Cells. Preprints 2021, 2021070278 (doi: 10.20944/preprints202107.0278.v1). Sianipar, N.F.; Hadisaputri, Y.E.; Assidqi, K.; Salam, S.; Yusuf, M.; Destiarani, W.; Purnamaningsih, R.; So, I.G. Characterization and Investigation of Stigmasterol Isolated from Rodent Tuber Mutant Plant (Typhonium flagelliforme), Its Molecular Docking as Anticancer on MF-7 Cells. Preprints 2021, 2021070278 (doi: 10.20944/preprints202107.0278.v1).

Abstract

Typhonium flagelliforme is an Indonesian herbal plant used and applied traditionally to treat cancer diseases. Gamma rays have irradiated rodent tuber mutant plant at six doses gray to in-crease the chemical compounds of anticancer activity. The effect of isolated compounds from ro-dent tuber mutant plants has never been studied and published yet. Our study unveiled the poten-tial of stigmasterol as a remarkable cytotoxic agent and the significant contribution of NMR spectroscopy, IR, Mass spectra, QTOF MS towards the isolation and identification of this anti-cancer agent. Stigmasterol was isolated from T. flagelliforme mutant plant. Stigmasterol was more effective against MCF-7 cells with an IC50 value of 0.1623 µM than Cisplatin with IC50 value 13.2 µM. It is the most potential and active fraction in the human breast cancer cell line. The mo-lecular docking study analyzed the chemical profile of stigmasterol to confirm the receptor in agonist binding sites. The prediction of the toxicity of stigmasterol compounds using in silico and analysis of its interaction with the receptor can act as a competitive regulator with a high-affinity binding site on FXR. Stigmasterol has potential as a candidate for an anticancer drug that pro-moting further clinical action.

Subject Areas

Typhonium flagelliforme; MCF-7 cell line; stigmasterol; agonistic; mutant plant

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.